TP53 and cancer: Overexpression of ARF in cancer has been mostly considered a byproduct of p53 mutation due to the previously mentioned negative feedback loop, and generally correlated with better prognosis (Kamijo et al., 1998; Silva et al., 2001; Song et al., 2014).